Welcome to the Investor Relations section of Vitruvia. This area is dedicated to keeping shareholders and potential investors up to date with relevant information on Vitruvia and its shares.

Press releases

Vitruvia Medical’s first Circular Clinic Supply Center for robotic instruments goes live with first customers

Vitruvia is the first European service provider to specialize in circular systems for highly…

AI-controlled cleaning systems for surgical robots

The use of medical products and technology in operating theaters is highly resource-intensive and…

Vitruvia group grows business

LT technologies GmbH & Co KG, founded in 2010, joined Vitruvia Medical AG in February 2021. The…

More Press releases

Ad-hoc News

Vitruvia Medical AG: Listing on Munich Stock Exchange

Effective today, the shares of Vitruvia Medical AG are trading on the Munich Stock Exchange.

Key performance indicators and reportsVitruvia Medical AG share

Number of sharesThe share capital is CHF 1,770,143.00 and is divided into 1,770,143 registered shares, each with a nominal value of CHF 1.00.
Availability of sharesAll registered shares are freely transferable.
End of fiscal yearDecember 31
Stock exchangeMunich Stock Exchange
Market segmentGeneral open market
Initial listingMay 11, 2021

Course data and key figures (as of July 23, 2021)

Last share priceEUR 13,90
Difference previous day0,0 %
Previous closeEUR 13,90
OpenEUR 13,90
HighEUR 13,90
LowEUR 13,90
Mkt. Cap.EUR 24,6M

Your contact

Markus A. Bertschin
President of the Board of Directors

T +41 (0)44 915 33 78
M +41 (0)79 233 26 09

Vitruvia Medical AG
Kesselackerstrasse 18
CH-5611 Anglikon I Swiss

Torsten Cejka
Board of Directors

T +41 (0)44 915 33 78
M +49 (0) 173 887 18 11

Vitruvia Medical AG
Germaniastraße 18-20
12099 Berlin I Germany